Achieve Life Sciences, Inc. Total Liabilities
Achieve Life Sciences, Inc. (ACHV) had Total Liabilities of $205.12 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-11
- 2026-06-30: Liabilities $205.12M.
- 2026-03-31: Liabilities $22.43M.
- 2025-12-31: Liabilities $20.27M.
- 2025-09-30: Liabilities $18.43M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $205.12M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $22.43M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $20.27M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $18.43M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $17.27M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $17.08M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $17.73M 10-K · filed 2026-03-24 | |
| 2024-09-30 | $16.54M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $22.51M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $20.57M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $20.82M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $20.30M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $19.22M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $20.36M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $21.67M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $22.68M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $20.82M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $19.18M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $19.47M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $3.10M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $4.71M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $3.57M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $3.01M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $1.94M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $1.92M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $1.66M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $3.03M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $3.35M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $3.25M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $4.31M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $3.28M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $2.98M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $2.78M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $2.32M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $2.01M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $2.35M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $1.77M 10-Q · filed 2017-07-31 | |
| 2017-03-31 | $2.01M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $3.20M 10-K · filed 2018-03-01 | $8.50M 10-K · filed 2017-02-23 |
| 2016-09-30 | $10.65M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $13.95M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $14.63M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $20.77M 10-K · filed 2017-02-23 | |
| 2015-09-30 | $29.46M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $35.16M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $16.36M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $22.23M 10-K · filed 2016-03-09 | |
| 2014-09-30 | $23.80M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $23.27M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $20.22M 10-Q · filed 2014-04-30 | |
| 2013-12-31 | $18.48M 10-K · filed 2015-03-26 | |
| 2013-09-30 | $18.10M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $16.62M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $15.09M 10-Q · filed 2013-05-02 | |
| 2012-12-31 | $15.81M 10-K · filed 2014-03-11 | |
| 2012-09-30 | $27.41M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $33.30M 10-Q · filed 2012-08-02 | |
| 2012-03-31 | $37.09M 10-Q · filed 2012-05-03 | |
| 2011-12-31 | $37.13M 10-K · filed 2013-03-07 | |
| 2011-09-30 | $34.66M 10-Q · filed 2011-11-03 | |
| 2011-06-30 | $44.33M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $45.79M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |